Skip to content
HomeMedia CenterPress releases FinancialJohnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference

Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference

Share Article
share to

New Brunswick, NJ (February 9th, 2022) - Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 43rd Annual Institutional Investors Conference on Tuesday, March 8th. Joseph J. Wolk, Executive Vice President and Chief Financial Officer, will represent the Company in a session scheduled at 1:05 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Media Contact
Lindsay Hyman
(732) 524-6297

Investor Contact
Lisa Romanko
(732)524-2034

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.